deoxypyridinoline has been researched along with Thyroid Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; San Millán, JL | 1 |
| Garber, J; Greenspan, SL; Lee, SL; Moses, AC; Rosen, HN; Ross, DS | 1 |
1 trial(s) available for deoxypyridinoline and Thyroid Neoplasms
| Article | Year |
|---|---|
Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates.
Topics: Alkaline Phosphatase; Amino Acids; Antineoplastic Agents; Biomarkers; Bone and Bones; Bone Resorption; Carcinoma, Papillary; Collagen; Collagen Type I; Creatinine; Diphosphonates; Double-Blind Method; Fasting; Humans; Osteocalcin; Osteolysis; Pamidronate; Peptides; Thyroid Neoplasms; Thyroxine | 1998 |
1 other study(ies) available for deoxypyridinoline and Thyroid Neoplasms
| Article | Year |
|---|---|
Thyroid hormone deficiency and postmenopausal status independently increase serum osteoprotegerin concentrations in women.
Topics: Adult; Amino Acids; Cohort Studies; Creatinine; Female; Humans; Hypothyroidism; Osteocalcin; Osteoprotegerin; Postmenopause; Prospective Studies; Thyroid Neoplasms; Thyrotropin; Thyroxine; Triiodothyronine | 2007 |